Montrose Environmental Group Announces Fourth Quarter and Full Year 2021 Results
Montrose Environmental Group, Inc. (MEG) reported a record-breaking full year revenue of $546.4 million for 2021, a 66.5% increase from the previous year. Fourth quarter revenue was $143.8 million, up 32.2%. Organic growth was 37.0% for the year. Despite a net loss of $25.3 million in 2021, down from $57.9 million in 2020, the company demonstrated strength in cash flow with $53.2 million after contingent payments. Adjusted EBITDA rose 42.5% to $77.6 million, with a margin of 14.2%. The company maintains a favorable outlook for 2022, projecting revenue between $520.0 million and $570.0 million.
- 2021 revenue increased 66.5% to $546.4 million.
- Fourth quarter revenue grew 32.2% to $143.8 million.
- Organic revenue growth reached 37.0% for the year.
- Adjusted EBITDA rose 42.5% to $77.6 million with a margin of 14.2%.
- Operating cash flow before contingent payments was a record $53.2 million.
- The company successfully completed six acquisitions in 2021.
- Net loss of $25.3 million in 2021, although improved from $57.9 million in 2020.
- Fourth quarter net loss of $1.5 million compared to net income of $0.8 million in the prior year.
- Adjusted EBITDA margin decreased from 16.6% to 14.2% year-over-year.
- Record Full Year Revenue, Organic Growth, Earnings, and Cash Flow -
- Strong Revenue Retention and New Customer Acquisition Fueling Growth -
- Continued
- Provides Outlook for Full Year 2022 -
Full Year and Fourth Quarter 2021 Highlights
-
2021 revenue of
increased$546.4 million 66.5% compared to the prior year. Fourth quarter revenue of increased$143.8 million 32.2% compared to the prior year quarter. -
2021 organic revenue growth was
37.0% including our CTEH response business and17.0% excluding CTEH. -
2021 cash flow from operations before the payment of
of acquisition related contingent consideration increased to a record$15.6 million .$53.2 million - Acquisitions in 2021 were funded almost entirely by operating cash flows. Despite completing two attractive acquisitions in the fourth quarter of 2021, our balance sheet remains very strong and leverage of 0.8 times did not increase from the prior quarter.
-
2021 net loss of
compared to a net loss of$25.3 million in the prior year. Fourth quarter net loss of$57.9 million compared to net income of$1.5 million in the prior year quarter, primarily due to changes in non-cash fair value adjustments.$0.8 million -
2021 Adjusted EBITDA1 of
grew$77.6 million 42.5% compared to the prior year. Adjusted EBITDA margin1 for 2021 was14.2% . Fourth quarter Adjusted EBITDA1 and Adjusted EBITDA margin1 were and$18.4 million 12.8% , respectively. - Inaugural and strong A rating from MSCI (which provides ESG ratings for the investment community) with continued recognition for excellence with environmental solutions, employee safety and strong labor management practices.
(1) |
Adjusted EBITDA and Adjusted EBITDA margin are non-GAAP measures. See the appendix to this release for a discussion of these measures, including how they are calculated and the reasons why we believe they provide useful information to investors, and a reconciliation for historical periods of Adjusted EBITDA to net (loss) income, the most directly comparable GAAP measure. |
Montrose Chief Executive Officer and Director,
“Despite an expected deceleration in our CTEH COVID-19 response business in the fourth quarter, which continues to outperform relative to historical levels, our organic growth for core environmental services accelerated given our capabilities related to greenhouse gas measurement and mitigation, PFAS remediation, and waste-to-energy services in particular. Coupled with the six acquisitions we closed in 2021 which added great talent and service capabilities to our team and have already started to create revenue synergy opportunities, we are excited about what the future holds for us.”
Full Year 2021 Results
Total revenue in the full year 2021 increased
Net loss was
Adjusted EBITDA1 increased
Fourth Quarter 2021 Results
Total revenue in the fourth quarter of 2021 increased
Net loss was
Adjusted EBITDA1 was
Operating Cash Flow, Liquidity and Capital Resources
Cash flow from operating activities for the full year ended
At
Recent Developments
In
In addition, in January, 2022, the Company entered into an interest rate swap transaction fixing the floating component of the interest rate on
Full Year 2022 Outlook
The Company is introducing its full year 2022 outlook for revenue to be in the range of
The Company’s 2022 forecast reflects an expectation of continued organic growth outperformance relative to the Company’s historical average of
The outlook does not include any benefit from future acquisitions that have not yet been completed.
Webcast and Conference Call
CEO
About Montrose
Montrose is a leading environmental solutions company focused on supporting commercial and government organizations as they deal with the challenges of today, and prepare for what’s coming tomorrow. With more than 2500 employees across over 80 locations around the world, Montrose combines deep local knowledge with an integrated approach to design, engineering, and operations, enabling the Company to respond effectively and efficiently to the unique requirements of each project. From comprehensive air measurement and laboratory services to regulatory compliance, emergency response, permitting, engineering, and remediation, Montrose delivers innovative and practical solutions that keep its clients on top of their immediate needs – and well ahead of the strategic curve. For more information, visit www.montrose-env.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may be identified by the use of words such as “intend,” “expect”, and “may”, and other similar expressions that predict or indicate future events or that are not statements of historical matters. Forward-looking statements are based on current information available at the time the statements are made and on management’s reasonable belief or expectations with respect to future events, and are subject to risks and uncertainties, many of which are beyond the Company’s control, that could cause actual performance or results to differ materially from the belief or expectations expressed in or suggested by the forward-looking statements. Further, many of these factors are, and may continue to be, amplified by the COVID-19 pandemic. Additional factors or events that could cause actual results to differ may also emerge from time to time, and it is not possible for the Company to predict all of them. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update any forward-looking statement to reflect future events, developments or otherwise, except as may be required by applicable law. Investors are referred to the Company’s filings with the
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME (In thousands, except per share data) |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
(Unaudited) |
|
|||||
|
|
For the Year Ended
|
|
|
For the Quarter Ended
|
|
||||||||||
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||
REVENUES |
|
$ |
546,413 |
|
|
$ |
328,243 |
|
|
$ |
143,794 |
|
|
$ |
108,741 |
|
COST OF REVENUES (exclusive of
|
|
|
369,028 |
|
|
|
215,492 |
|
|
|
96,366 |
|
|
|
73,377 |
|
SELLING, GENERAL AND ADMINISTRATIVE
|
|
|
117,658 |
|
|
|
85,546 |
|
|
|
34,793 |
|
|
|
20,736 |
|
FAIR VALUE CHANGES IN BUSINESS
|
|
|
24,372 |
|
|
|
12,942 |
|
|
|
337 |
|
|
|
(4,445 |
) |
DEPRECIATION AND AMORTIZATION |
|
|
44,810 |
|
|
|
37,274 |
|
|
|
11,665 |
|
|
|
10,190 |
|
(LOSS) INCOME FROM OPERATIONS |
|
|
(9,455 |
) |
|
|
(23,011 |
) |
|
|
633 |
|
|
|
8,883 |
|
OTHER EXPENSE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expense |
|
|
(2,546 |
) |
|
|
(20,268 |
) |
|
|
(637 |
) |
|
|
(2,734 |
) |
Interest expense—net |
|
|
(11,615 |
) |
|
|
(13,819 |
) |
|
|
(407 |
) |
|
|
(2,923 |
) |
Total other expenses—net |
|
|
(14,161 |
) |
|
|
(34,087 |
) |
|
|
(1,044 |
) |
|
|
(5,657 |
) |
(LOSS) INCOME BEFORE EXPENSE
|
|
|
(23,616 |
) |
|
|
(57,098 |
) |
|
|
(411 |
) |
|
|
3,226 |
|
INCOME TAX EXPENSE |
|
|
1,709 |
|
|
|
851 |
|
|
|
1,061 |
|
|
|
2,414 |
|
NET (LOSS) INCOME |
|
$ |
(25,325 |
) |
|
$ |
(57,949 |
) |
|
$ |
(1,472 |
) |
|
$ |
812 |
|
EQUITY ADJUSTMENT FROM FOREIGN
|
|
|
(35 |
) |
|
|
111 |
|
|
|
(18 |
) |
|
|
84 |
|
COMPREHENSIVE (LOSS) INCOME |
|
|
(25,360 |
) |
|
|
(57,838 |
) |
|
|
(1,490 |
) |
|
|
896 |
|
ACCRETION OF REDEEMABLE SERIES A-1
|
|
|
— |
|
|
|
(17,601 |
) |
|
|
— |
|
|
|
— |
|
REDEEMABLE SERIES A-1 PREFERRED
|
|
|
— |
|
|
|
(24,341 |
) |
|
|
— |
|
|
|
— |
|
CONVERTIBLE AND REDEEMABLE
|
|
|
(16,400 |
) |
|
|
(6,970 |
) |
|
|
(4,100 |
) |
|
|
(4,100 |
) |
NET LOSS ATTRIBUTABLE TO
|
|
|
(41,725 |
) |
|
|
(106,861 |
) |
|
|
(5,572 |
) |
|
|
(3,288 |
) |
WEIGHTED AVERAGE COMMON SHARES
|
|
|
26,724 |
|
|
|
16,479 |
|
|
|
29,503 |
|
|
|
24,909 |
|
NET LOSS PER SHARE ATTRIBUTABLE
|
|
$ |
(1.56 |
) |
|
$ |
(6.48 |
) |
|
$ |
(0.19 |
) |
|
$ |
(0.13 |
) |
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (In thousands, except share data) |
||||||||
|
|
|
|
|
|
|
||
ASSETS |
|
|
|
|
|
|
|
|
CURRENT ASSETS: |
|
|
|
|
|
|
|
|
Cash |
|
$ |
146,254 |
|
|
$ |
34,386 |
|
Restricted cash |
|
|
487 |
|
|
|
495 |
|
Accounts receivable—net |
|
|
98,513 |
|
|
|
54,102 |
|
Contract assets |
|
|
40,139 |
|
|
|
38,576 |
|
Prepaid and other current assets |
|
|
7,957 |
|
|
|
6,709 |
|
Income tax receivable |
|
|
508 |
|
|
|
— |
|
Total current assets |
|
|
293,858 |
|
|
|
134,268 |
|
NON-CURRENT ASSETS: |
|
|
|
|
|
|
|
|
Property and equipment—net |
|
|
31,521 |
|
|
|
34,399 |
|
Operating lease right-of-use asset—net |
|
|
23,532 |
|
|
|
— |
|
Finance lease right-of-use asset—net |
|
|
8,944 |
|
|
|
— |
|
|
|
|
311,944 |
|
|
|
274,667 |
|
Other intangible assets—net |
|
|
160,997 |
|
|
|
154,854 |
|
Other assets |
|
|
2,298 |
|
|
|
4,538 |
|
TOTAL ASSETS |
|
$ |
833,094 |
|
|
$ |
602,726 |
|
LIABILITIES, CONVERTIBLE AND REDEEMABLE SERIES A-2
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES: |
|
|
|
|
|
|
|
|
Accounts payable and other accrued liabilities |
|
|
68,936 |
|
|
|
34,621 |
|
Accrued payroll and benefits |
|
|
25,971 |
|
|
|
21,181 |
|
Business acquisitions contingent consideration, current |
|
|
31,450 |
|
|
|
49,902 |
|
Income tax payable |
|
|
— |
|
|
|
256 |
|
Current portion of operating lease liabilities |
|
|
6,888 |
|
|
|
— |
|
Current portion of finance lease liabilities |
|
|
3,512 |
|
|
|
— |
|
Current portion of long-term debt |
|
|
10,938 |
|
|
|
5,583 |
|
Total current liabilities |
|
|
147,695 |
|
|
|
111,543 |
|
NON-CURRENT LIABILITIES: |
|
|
|
|
|
|
|
|
Business acquisitions contingent consideration, long-term |
|
|
4,350 |
|
|
|
4,565 |
|
Other non-current liabilities |
|
|
100 |
|
|
|
2,523 |
|
Deferred tax liabilities—net |
|
|
4,006 |
|
|
|
2,815 |
|
Conversion option |
|
|
23,081 |
|
|
|
20,886 |
|
Operating lease liability—net of current portion |
|
|
16,859 |
|
|
|
— |
|
Finance lease liability—net of current portion |
|
|
5,756 |
|
|
|
— |
|
Long-term debt—net of deferred financing fees |
|
|
161,818 |
|
|
|
170,321 |
|
Total liabilities |
|
|
363,665 |
|
|
|
312,653 |
|
COMMITMENTS AND CONTINGENCIES |
|
|
|
|
|
|
|
|
CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK |
|
|
|
|
|
|
|
|
Authorized, issued and outstanding shares: 17,500 at |
|
|
152,928 |
|
|
|
152,928 |
|
STOCKHOLDERS’ EQUITY: |
|
|
|
|
|
|
|
|
Common stock, |
|
|
— |
|
|
|
— |
|
Additional paid-in capital |
|
|
464,143 |
|
|
|
259,427 |
|
Accumulated deficit |
|
|
(147,678 |
) |
|
|
(122,353 |
) |
Accumulated other comprehensive income |
|
|
36 |
|
|
|
71 |
|
Total stockholders’ equity |
|
|
316,501 |
|
|
|
137,145 |
|
TOTAL LIABILITIES, CONVERTIBLE AND REDEEMABLE SERIES A-2
|
|
$ |
833,094 |
|
|
$ |
602,726 |
|
CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) |
||||||||
|
|
For the Year Ended
|
|
|||||
|
|
2021 |
|
|
2020 |
|
||
OPERATING ACTIVITIES: |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(25,325 |
) |
|
$ |
(57,949 |
) |
Adjustments to reconcile net loss to net cash
|
|
|
|
|
|
|
|
|
Provision for bad debt |
|
|
1,135 |
|
|
|
4,532 |
|
Depreciation and amortization |
|
|
44,810 |
|
|
|
37,274 |
|
Amortization of right-of-use asset |
|
|
8,151 |
|
|
|
— |
|
Stock-based compensation expense |
|
|
10,321 |
|
|
|
4,849 |
|
Fair value changes in financial instruments |
|
|
2,195 |
|
|
|
20,319 |
|
Fair value changes in business acquisitions
|
|
|
24,372 |
|
|
|
12,942 |
|
Deferred income taxes |
|
|
1,709 |
|
|
|
851 |
|
Amortization of deferred financing costs |
|
|
404 |
|
|
|
1,810 |
|
Debt extinguishment costs |
|
|
4,052 |
|
|
|
— |
|
Other |
|
|
(599 |
) |
|
|
278 |
|
Changes in operating assets and liabilities—net of acquisitions: |
|
|
|
|
|
|
|
|
Accounts receivable and contract assets |
|
|
(36,164 |
) |
|
|
(19,202 |
) |
Prepaid expenses and other current assets |
|
|
(886 |
) |
|
|
(956 |
) |
Accounts payable and other accrued liabilities |
|
|
23,996 |
|
|
|
601 |
|
Accrued payroll and benefits |
|
|
3,244 |
|
|
|
6,072 |
|
Payment of contingent consideration and other assumed purchase price obligations |
|
|
(15,628 |
) |
|
|
(6,390 |
) |
Change in operating leases |
|
|
(7,944 |
) |
|
|
— |
|
Other assets |
|
|
(262 |
) |
|
|
(3,181 |
) |
Net cash provided by operating activities |
|
$ |
37,581 |
|
|
$ |
1,850 |
|
INVESTING ACTIVITIES: |
|
|
|
|
|
|
|
|
Proceeds from property insurance |
|
|
413 |
|
|
|
— |
|
Purchases of property and equipment |
|
|
(6,885 |
) |
|
|
(7,206 |
) |
Proceeds received from the sale of property and equipment |
|
|
597 |
|
|
|
20 |
|
Proprietary software development and other software costs |
|
|
(699 |
) |
|
|
(570 |
) |
Payment of assumed purchase price obligations |
|
|
(9,336 |
) |
|
|
— |
|
Proceeds from net working capital adjustment related to acquisitions |
|
|
— |
|
|
|
1,939 |
|
Cash paid for acquisitions—net of cash acquired |
|
|
(55,731 |
) |
|
|
(173,923 |
) |
Net cash used in investing activities |
|
$ |
(71,641 |
) |
|
$ |
(179,740 |
) |
FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
|
Proceeds from line of credit |
|
|
109,000 |
|
|
|
104,390 |
|
Payments on line of credit |
|
|
(109,000 |
) |
|
|
(201,980 |
) |
Proceeds from term loans |
|
|
175,000 |
|
|
|
175,000 |
|
Repayment of term loans |
|
|
(173,905 |
) |
|
|
(49,844 |
) |
Payment of contingent consideration and other assumed purchase
|
|
|
(9,865 |
) |
|
|
(6,004 |
) |
Repayment of finance leases |
|
|
(2,711 |
) |
|
|
(2,848 |
) |
Proceeds from issuance of common stock
|
|
|
169,783 |
|
|
|
161,288 |
|
Payments of deferred offering costs |
|
|
(446 |
) |
|
|
(4,164 |
) |
Prepayment premium on credit facility |
|
|
— |
|
|
|
(351 |
) |
Debt issuance cost |
|
|
(2,590 |
) |
|
|
(4,866 |
) |
Proceeds from issuance of common stock for exercised
|
|
|
7,237 |
|
|
|
408 |
|
Issuance of series A-1 and series A-2
|
|
|
— |
|
|
|
173,664 |
|
Redemption of the series A-1 preferred stock |
|
|
— |
|
|
|
(131,821 |
) |
Dividend payment to the series A-2 shareholders |
|
|
(16,400 |
) |
|
|
(6,970 |
) |
Net cash provided by financing activities |
|
$ |
146,103 |
|
|
$ |
205,902 |
|
CHANGE IN CASH, CASH EQUIVALENTS AND
|
|
$ |
112,043 |
|
|
$ |
28,012 |
|
Foreign exchange impact on cash balance |
|
|
(183 |
) |
|
|
(15 |
) |
CASH, CASH EQUIVALENTS AND RESTRICTED CASH: |
|
|
|
|
|
|
|
|
Beginning of year |
|
|
34,881 |
|
|
|
6,884 |
|
End of period |
|
$ |
146,741 |
|
|
$ |
34,881 |
|
(continued in next page) |
|
CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) |
||||||||
|
|
For the Year Ended
|
|
|||||
|
|
2021 |
|
|
2020 |
|
||
SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION: |
|
|
|
|
|
|
|
|
Cash paid for interest |
|
$ |
5,012 |
|
|
$ |
11,947 |
|
Cash paid for income tax |
|
$ |
412 |
|
|
$ |
171 |
|
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
|
Preferred stock deemed dividend—net of return from holders |
|
$ |
— |
|
|
$ |
24,341 |
|
Redemption of preferred stock in common shares |
|
$ |
— |
|
|
$ |
26,801 |
|
Accrued purchases of property and equipment |
|
$ |
790 |
|
|
$ |
432 |
|
Property and equipment purchased under finance leases |
|
$ |
1,766 |
|
|
$ |
2,113 |
|
Accretion of the redeemable series A-1 preferred stock to redeemable value |
|
$ |
— |
|
|
$ |
17,601 |
|
Common stock issued to acquire new businesses |
|
$ |
8,320 |
|
|
$ |
25,000 |
|
Acquisitions unpaid contingent consideration |
|
$ |
35,800 |
|
|
$ |
54,467 |
|
Acquisitions contingent consideration paid in shares |
|
$ |
26,084 |
|
|
$ |
— |
|
Offering costs included in accounts payable and other accrued liabilities |
|
$ |
183 |
|
|
$ |
— |
|
(concluded) |
Non-GAAP Financial Information
In addition to our results under GAAP, in this release we also present certain other supplemental financial measures of financial performance that are not required by, or presented in accordance with, GAAP, including Adjusted EBITDA and Adjusted EBITDA margin. We calculate Adjusted EBITDA as net (loss) income before interest expense, income tax expense (benefit) and depreciation and amortization, adjusted for the impact of certain other items, including stock-based compensation expense and acquisition-related costs, as set forth in greater detail in the table below. Adjusted EBITDA margin represents Adjusted EBITDA as a percentage of revenues for a given period.
Adjusted EBITDA and Adjusted EBITDA margin are two of the primary metrics used by management to evaluate our financial performance and compare it to that of our peers, evaluate the effectiveness of our business strategies, make budgeting and capital allocation decisions and in connection with our executive incentive compensation. These measures are also frequently used by analysts, investors and other interested parties to evaluate companies in our industry. Further, we believe they are helpful in highlighting trends in our operating results because they allow for more consistent comparisons of financial performance between periods by excluding gains and losses that are non-operational in nature or outside the control of management, as well as items that may differ significantly depending on long-term strategic decisions regarding capital structure, the tax jurisdictions in which we operate and capital investments.
These non-GAAP measures do, however, have certain limitations and should not be considered as an alternative to net (loss) income or any other performance measure derived in accordance with GAAP. Our presentation of Adjusted EBITDA and Adjusted EBITDA margin should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items for which we may make adjustments. In addition, Adjusted EBITDA and Adjusted EBITDA margin may not be comparable to similarly titled measures used by other companies in our industry or across different industries, and other companies may not present these or similar measures. Management compensates for these limitations by using these measures as supplemental financial metrics and in conjunction with our results prepared in accordance with GAAP. We encourage investors and others to review our financial information in its entirety, not to rely on any single measure and to view Adjusted EBITDA and Adjusted EBITDA margin in conjunction with the related GAAP measures.
Additionally, we have provided estimates regarding Adjusted EBITDA for 2022. These projections account for estimates of revenue, operating margins and corporate and other costs. However, we cannot reconcile our projection of Adjusted EBITDA to net (loss) income, the most directly comparable GAAP measure, without unreasonable efforts because of the unpredictable or unknown nature of certain significant items excluded from Adjusted EBITDA and the resulting difficulty in quantifying the amounts thereof that are necessary to estimate net (loss) income. Specifically, we are unable to estimate for the future impact of certain items, including income tax (expense) benefit, stock-based compensation expense, fair value changes and the accounting for the issuance of the Series A-2 preferred stock. We expect the variability of these items could have a significant impact on our reported GAAP financial results.
Reconciliation of Net (Loss) Income to Adjusted EBITDA (in thousands) |
||||||||||||||||
|
|
For the Year Ended
|
|
|
For the Quarter Ended
|
|
||||||||||
(in thousands) |
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||
Net (loss) income |
|
$ |
(25,325 |
) |
|
$ |
(57,949 |
) |
|
$ |
(1,472 |
) |
|
$ |
812 |
|
Interest expense |
|
|
11,615 |
|
|
|
13,819 |
|
|
|
407 |
|
|
|
2,923 |
|
Income tax expense |
|
|
1,709 |
|
|
|
851 |
|
|
|
1,061 |
|
|
|
2,414 |
|
Depreciation and amortization |
|
|
44,810 |
|
|
|
37,274 |
|
|
|
11,665 |
|
|
|
10,190 |
|
EBITDA |
|
$ |
32,809 |
|
|
$ |
(6,005 |
) |
|
$ |
11,661 |
|
|
$ |
16,339 |
|
Stock-based compensation (1) |
|
|
10,321 |
|
|
|
4,849 |
|
|
|
3,734 |
|
|
|
1,410 |
|
Start-up losses and investment in new services (2) |
|
|
4,407 |
|
|
|
2,182 |
|
|
|
1,131 |
|
|
|
899 |
|
Acquisition costs (3) |
|
|
2,088 |
|
|
|
4,344 |
|
|
|
432 |
|
|
|
577 |
|
Fair value changes in financial instruments (4) |
|
|
2,195 |
|
|
|
20,319 |
|
|
|
544 |
|
|
|
2,827 |
|
Expenses related to financing transactions (5) |
|
|
50 |
|
|
|
378 |
|
|
|
— |
|
|
|
101 |
|
Fair value changes in business acquisitions
|
|
|
24,372 |
|
|
|
12,942 |
|
|
|
337 |
|
|
|
(4,445 |
) |
Short term purchase accounting fair value
|
|
|
— |
|
|
|
243 |
|
|
|
— |
|
|
|
— |
|
Public offering expense (8) |
|
|
— |
|
|
|
7,657 |
|
|
|
— |
|
|
|
749 |
|
Discontinued service lines and closing of Berkley
|
|
|
— |
|
|
|
5,662 |
|
|
|
— |
|
|
|
(1,864 |
) |
Other losses and expenses(10) |
|
|
1,400 |
|
|
|
1,905 |
|
|
|
554 |
|
|
|
1,726 |
|
Adjusted EBITDA |
|
$ |
77,642 |
|
|
$ |
54,476 |
|
|
$ |
18,393 |
|
|
$ |
18,319 |
|
(1) |
Represents non-cash stock-based compensation expenses related to (i) option awards issued to employees, (ii) restricted stock grants issued to directors and selected employees, (iii) and stock appreciation rights grants issued to selected employees. |
|
(2) |
Represent start-up losses related to losses incurred on (i) the expansion of lab testing methods and lab capacity, including into new geographies, (ii) introduction of new software and consulting service lines (iii) expansion into |
|
(3) |
Includes financial and tax diligence, consulting, legal, valuation, accounting and travel costs and acquisition-related incentives related to our acquisition activity. |
|
(4) |
Amounts relate to the change in fair value of the embedded derivatives and warrant options attached to the Series A-1 preferred stock and the Series A-2 preferred stock. |
|
(5) |
Amounts represent non-capitalizable expenses associated with refinancing and amending our debt facilities. |
|
(6) |
Reflects the difference between the expected settlement value of acquisition related earn-out payments at the time of the closing of acquisitions and the expected (or actual) value of earn-outs at the end of the relevant period. |
|
(7) |
Purchase accounting fair value adjustment to deferred revenue represents the impact of the fair value adjustment to the carrying value of deferred revenue as of the date of acquisition of ECT2. |
|
(8) |
Represents expenses incurred by us to prepare for our initial public offering, costs from IPO-related bonuses, and costs related to the |
|
(9) |
Represents loss (earnings) from the Discontinued Service Lines and the Berkeley lab. See “—Overview—Key Factors that Affect Our Business and Our Results” in the Management’s Discussion and Analysis of Financial Condition and Results of Operations in our 2021 10-K. |
|
(10) |
Represents non-operational charges incurred as a result of lease abandonments and non-capitalizable costs related to the implementation of a new ERP, net of insurance gains. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220228005983/en/
Investor Relations:
(949) 988-3383
ir@montrose-env.com
Media Relations:
(646) 361-1427
Montrose@icrinc.com
Source:
FAQ
What was Montrose Environmental Group's revenue for 2021?
How much did Montrose's revenue increase in the fourth quarter of 2021?
What was Montrose's organic growth rate for 2021?
What is Montrose's projected revenue range for 2022?